GEODE CAPITAL MANAGEMENT, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 60 filers reported holding CARDLYTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$12,285,407
+186.4%
744,472
+9.7%
0.00%0.0%
Q2 2023$4,288,859
+97.8%
678,617
+6.2%
0.00%
Q1 2023$2,168,488
+59968.9%
638,730
+2.3%
0.00%
-100.0%
Q4 2022$3,610
-99.9%
624,664
+4.5%
0.00%0.0%
Q3 2022$5,620,000
-59.0%
597,895
-2.6%
0.00%
-50.0%
Q2 2022$13,692,000
-58.2%
613,738
+3.0%
0.00%
-50.0%
Q1 2022$32,758,000
-13.0%
595,824
+4.6%
0.00%
-20.0%
Q4 2021$37,663,000
-17.7%
569,883
+4.5%
0.01%
-16.7%
Q3 2021$45,782,000
-34.7%
545,416
-1.2%
0.01%
-40.0%
Q2 2021$70,076,000
+26.3%
552,088
+9.2%
0.01%
+25.0%
Q1 2021$55,468,000
-7.5%
505,636
+20.4%
0.01%
-20.0%
Q4 2020$59,965,000
+113.8%
420,015
+5.7%
0.01%
+100.0%
Q3 2020$28,050,000
+12.0%
397,491
+11.0%
0.01%0.0%
Q2 2020$25,050,000
+141.2%
357,969
+20.5%
0.01%
+66.7%
Q1 2020$10,385,000
-65.7%
297,071
-38.4%
0.00%0.0%
Q4 2019$30,316,000
+327.6%
482,282
+128.0%
0.00%
+50.0%
Q3 2019$7,089,000
+50.7%
211,497
+16.8%
0.00%
+100.0%
Q2 2019$4,704,000
+148.1%
181,086
+57.9%
0.00%
Q1 2019$1,896,000
+9.5%
114,654
-28.4%
0.00%
Q4 2018$1,732,000
-7.0%
160,032
+115.1%
0.00%
-100.0%
Q3 2018$1,863,000
+54.0%
74,406
+33.7%
0.00%
Q2 2018$1,210,000
+82.0%
55,647
+22.3%
0.00%
Q1 2018$665,00045,5110.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders